Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment
Memorial Sloan Kettering Cancer Center · NCT02422550
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 937
- US sites recruiting
- 7
- Study start
- April 9, 2015
- Record last updated
- August 11, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Magnetic resonance imaging (MRI) is currently one of the standard diagnostic imaging methods used to diagnose tumor stage before treatment in the Radiation Oncology Department. It is also used to check responses to radiation after treatment. However, MRI isn't traditionally used in planning for radiation treatment or in checking treated tumor and tissue changes during radiation treatment. The goal is to find out the possible benefits of MRI imaging techniques in these settings of radiation treatment. The research aims are to study the possibility of using devices with new abilities such as the MR-Linac. The MR-Linac combines a radiation treatment machine with a diagnostic MRI scanner. This device will improve the quality of MRI-guided radiation treatment. The MR-Linac has functions that are currently not available in other combined imaging and radiation delivery devices. The MR-Linac does not provide additional imaging capabilities that are not currently available in other imaging devices.
Participating in this study would NOT change the current treatment plans, this will allow the investigators to use the MRI methods in research and future patient care.
Being studied: MRI or CT
Conditions: Radiation Therapy
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Men and women age 18 or older
Exclusion Criteria
- Anyone who would be normally excluded from undergoing an MRI examination as per Memorial Hospital for Cancer and Allied Diseases Screening Questionnaire
- Participants/volunteers with a pacemaker, aneurysm clip or any other condition that would warrant avoidance of a strong magnetic field
- Female participants/volunteers who are pregnant or nursing
- Participants/Volunteers who are unable to comply or complete the MRI exam due to claustrophobia or high levels of anxiety
- Participants/Volunteers from the vulnerable population, as defined by 45 CFR 46.
- Participants at higher risk due to age, frailty, or the emergent nature of their condition.
Recruiting US locations
Memorial Sloan Kettering Basking Ridge (Consent only)
Basking Ridge, NJ 07920
Site contact: Nancy Lee, MD · 212-639-3341
Memorial Sloan Kettering Monmouth (Consent only)
Middletown, NJ 07748
Site contact: Nancy Lee, MD · 212-639-3341
Memorial Sloan Kettering Bergen (Consent only )
Montvale, NJ 07645
Site contact: Nancy Lee, MD · 212-639-3341
Memorial Sloan Kettering Commack (Consent Only)
Commack, NY 11725
Site contact: Nancy Lee, MD · 212-639-3341
Memorial Sloan Kettering Westchester (Consent only)
Harrison, NY 10604
Site contact: Nancy Lee, MD · 212-639-3341
Memorial Sloan Kettering Cancer Center
New York, NY 10065
Site contact: Nancy Lee, MD · 212-639-3341
Memorial Sloan Kettering Nassau (Consent only)
Uniondale, NY 11553
Site contact: Nancy Lee, MD · 212-639-3341
Study contacts (from the official record)
- Nancy Lee, MD · 212-639-3341
- Simon Powell, MD · 212-639-6072
Similar studies in New Jersey
All healthy volunteers studies in New Jersey →- RecruitingHealthy volunteersPhase 1
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Arcutis Biotherapeutics, Inc.
- Location
- Fair Lawn, NJ + 6 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008)
Merck Sharp & Dohme LLC
- Location
- Marlton, NJ + 5 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Jersey City, NJ + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
Study of Single Doses of HBS-104 in Acutely Sleep-deprived Healthy Participants
Harmony Biosciences Management, Inc.
- Location
- Eatontown, NJ
- Eligibility basics
- Ages 18–55